Stay updated on Pembrolizumab in MM Residual Disease Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in MM Residual Disease Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in MM Residual Disease Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Added the topic Multiple myeloma and the related topic MedlinePlus Genetics. Updated the site revision from v3.4.3 to v3.5.0.
    Difference
    0.2%
    Check dated 2026-03-24T22:57:25.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    Removed the disease label 'Multiple myeloma,' the related topics header, and the 'MedlinePlus Genetics' resource.
    Difference
    0.2%
    Check dated 2026-03-17T20:21:15.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    Revision: v3.4.3 was published, replacing the previous v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-10T14:40:34.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    31 days ago
    Change Detected
    Summary
    Added related topics: Multiple myeloma and MedlinePlus Genetics to the page.
    Difference
    0.2%
    Check dated 2026-02-24T09:07:56.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    Revision: v3.4.2 updated from v3.4.1; no study content or functionality changes are visible. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-17T03:08:07.000Z thumbnail image
  7. Check
    45 days ago
    Change Detected
    Summary
    Revision: v3.4.1 has been added to the page. Older non-core revision notes (v3.4.0) and non-essential items such as the 'Multiple myeloma' topic and related topics, plus the funding-status notice, were removed.
    Difference
    0.6%
    Check dated 2026-02-09T22:21:33.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in MM Residual Disease Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in MM Residual Disease Clinical Trial page.